View of the drug product manufacturing laboratory in biologics and A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman/file photo Post navigation Previous: Catalent, facing pressure from Elliott, had other activists in stock